Assenagon Asset Management S.A. sells Cara Therapeutics, Inc. (NASDAQ:CARA) stock.
According to the most recent report filed with the Securities and Exchange Commission by Assenagon Asset Management S.A., the company’s holdings in Cara Therapeutics, Inc. …